Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10653803
Cellular micromotors and uses thereof
granted -
US 10654842
Dopamine D3 receptor antagonist compounds
granted -
US 10654829
Crystalline forms and compositions of CFTR modulators
granted -
US 10653797
Compounds and compositions for targeting brain injuries and methods of use thereof
granted -
US 10653800
Oligonucleotide-based probes for detection of bacterial nucleases
granted -
US 10653780
Amino lipids and methods for the delivery of nucleic acids
granted -
US 10653777
Pharmaceutical compositions comprising meloxicam
granted -
US 10653782
Retroviral particles expressing Sirt1 embedded within PPCN
granted -
US 10653778
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 10653774
Compositions and methods for activating “stimulator of interferon gene”-dependent signalling
granted -
US 10653173
Method for masking unpleasant taste
granted -
US 10653755
Compositions and methods for treatment of homocystinuria
granted -
US 10653743
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
granted -
US 10653749
Targeting GIV-GEF-GI signaling for treating diverse diseases
granted -
US 10653727
Use of gram negative species to treat atopic dermatitis
granted -
US 10653725
Methods for improving health of farmed fish
granted -
US 10653652
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
granted -
US 10653721
Peroxide formulations and methods and applicators for using the same
granted -
WO 2020094634
PROMÉDICAMENTS DE THIOPHÈNE DE NALTROXÈNE POUR COMPOSITIONS INJECTABLES À ACTION PROLONGÉE ET PROCÉDÉS ASSOCIÉS
granted -
WO 2020095183
COMBINAISON POUR LE TRAITEMENT DU CANCER
granted -
US 10646475
SHMT inhibitors
granted -
US 10647711
Azepin-2-one derivatives as RSV inhibitors
granted -
US 10646575
Heterocyclic degronimers for target protein degradation
granted -
US 10646438
Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.